Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 350

1.

[Risk factors associated with non-alcoholic fatty liver disease: a case-control study].

Caballería L, Arteaga I, Pera G, Rodríguez L, Alumà A, Auladell MA, Torán P.

Med Clin (Barc). 2013 Sep 21;141(6):233-9. doi: 10.1016/j.medcli.2012.11.034. Epub 2013 Apr 17. Spanish.

PMID:
23601740
2.

Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males.

Wang R, Lu Q, Feng J, Yin F, Qin C, Liu B, Liu Y, Liu X.

Endocrine. 2012 Feb;41(1):70-5. doi: 10.1007/s12020-011-9511-0. Epub 2011 Jul 28.

PMID:
21796479
3.

[Non-invasive markers of fibrosis in the diagnosis of non-alcoholic fatty liver disease].

Arteaga I, Buezo I, Expósito C, Pera G, Rodríguez L, Alumà A, Auladell MA, Torán P, Caballería L.

Gastroenterol Hepatol. 2014 Nov;37(9):503-10. doi: 10.1016/j.gastrohep.2014.03.009. Epub 2014 Apr 17. Spanish.

PMID:
24746708
4.

Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease.

Oh HJ, Kim TH, Sohn YW, Kim YS, Oh YR, Cho EY, Shim SY, Shin SR, Han AL, Yoon SJ, Kim HC.

Korean J Hepatol. 2011 Mar;17(1):27-36. doi: 10.3350/kjhep.2011.17.1.27.

5.

Association of adiponectin with hepatic steatosis: a study of 1,349 subjects in a random population sample.

Flechtner-Mors M, George SN, Oeztuerk S, Haenle MM, Koenig W, Imhof A, Boehm BO, Graeter T, Mason RA, Kratzer W, Akinli AS; EMIL-Study group.

BMC Res Notes. 2014 Apr 3;7:207. doi: 10.1186/1756-0500-7-207.

6.

Gamma-glutamyl transpeptidase level associated with metabolic syndrome and proinflammatory parameters in the young Roma population in eastern Slovakia: a population-based study.

Jarcuska P, Janicko M, Drazilová S, Senajová G, Veselíny E, Fedacko J, Siegfried L, Kristian P, Tkác M Jr, Pella D, Mareková M, Gecková AM, Jarcuska P; HepaMeta Team.

Cent Eur J Public Health. 2014 Mar;22 Suppl:S43-50.

7.
8.

Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.

Dassanayake AS, Kasturiratne A, Rajindrajith S, Kalubowila U, Chakrawarthi S, De Silva AP, Makaya M, Mizoue T, Kato N, Wickremasinghe AR, de Silva HJ.

J Gastroenterol Hepatol. 2009 Jul;24(7):1284-8. doi: 10.1111/j.1440-1746.2009.05831.x. Epub 2009 May 19.

PMID:
19476560
9.

Risk factors associated with non-alcoholic fatty liver disease in subjects from primary care units. A case-control study.

Caballería L, Auladell MA, Torán P, Pera G, Miranda D, Alumà A, Casas JD, Muñoz L, Sanchez C, Tibau A, Birules M, Canut S, Bernad J, Aubà J, Aizpurua MM, Alcaraz E.

BMC Gastroenterol. 2008 Oct 3;8:44. doi: 10.1186/1471-230X-8-44.

10.

Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.

Alkassabany YM, Farghaly AG, El-Ghitany EM.

Arab J Gastroenterol. 2014 Jun;15(2):76-81. doi: 10.1016/j.ajg.2014.05.002. Epub 2014 Jul 10.

PMID:
25097051
11.

Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain.

Caballería L, Pera G, Auladell MA, Torán P, Muñoz L, Miranda D, Alumà A, Casas JD, Sánchez C, Gil D, Aubà J, Tibau A, Canut S, Bernad J, Aizpurua MM.

Eur J Gastroenterol Hepatol. 2010 Jan;22(1):24-32. doi: 10.1097/MEG.0b013e32832fcdf0.

PMID:
19730384
12.

Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention.

Cankurtaran M, Tayfur O, Yavuz BB, Geyik S, Akhan O, Arslan S.

Acta Gastroenterol Belg. 2007 Jul-Sep;70(3):253-9.

PMID:
18074733
13.

Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome.

Hamaguchi M, Takeda N, Kojima T, Ohbora A, Kato T, Sarui H, Fukui M, Nagata C, Takeda J.

World J Gastroenterol. 2012 Apr 7;18(13):1508-16. doi: 10.3748/wjg.v18.i13.1508.

14.

Prevalence and etiology of abnormal liver tests in an adult population in Jilin, China.

Zhang H, He SM, Sun J, Wang C, Jiang YF, Gu Q, Feng XW, Du B, Wang W, Shi XD, Zhang SQ, Li WY, Niu JQ.

Int J Med Sci. 2011 Mar 25;8(3):254-62.

15.
16.

[Non-alcoholic fatty liver in children and adolescents with excess weight and obesity].

Guijarro de Armas MG, Monereo Megías S, Navea Aguilera C, Merino Viveros M, Vega Piñero MB.

Med Clin (Barc). 2015 Jan 20;144(2):55-8. doi: 10.1016/j.medcli.2014.02.018. Epub 2014 Apr 24. Spanish.

PMID:
24768200
17.

The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents.

Fu CC, Chen MC, Li YM, Liu TT, Wang LY.

Ann Acad Med Singapore. 2009 Jan;38(1):15-7.

18.

Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.

Ballestri S, Zona S, Targher G, Romagnoli D, Baldelli E, Nascimbeni F, Roverato A, Guaraldi G, Lonardo A.

J Gastroenterol Hepatol. 2016 May;31(5):936-44. doi: 10.1111/jgh.13264. Review.

PMID:
26667191
19.

Non-alcoholic fatty liver disease: An early mediator predicting metabolic syndrome in obese children?

Fu JF, Shi HB, Liu LR, Jiang P, Liang L, Wang CL, Liu XY.

World J Gastroenterol. 2011 Feb 14;17(6):735-42. doi: 10.3748/wjg.v17.i6.735.

20.

Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome.

Marchesini G, Avagnina S, Barantani EG, Ciccarone AM, Corica F, Dall'Aglio E, Dalle Grave R, Morpurgo PS, Tomasi F, Vitacolonna E.

J Endocrinol Invest. 2005 Apr;28(4):333-9.

PMID:
15966506

Supplemental Content

Support Center